Future studies will specifically evaluate CD248-targeting strategies in chronic myocarditis models to determine whether combinatorial or context-dependent targeting approaches might optimize therapeutic outcomes across the spectrum of fibrotic cardiovascular diseases. The gene discussed is CD248; the disease is cardiovascular disorder.